T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study
Title:
T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study
Author:
Andreone, P. Berg, T. Pol, S. Roberts, S. Younossi, Z. Diago, M. Lawitz, E.J. Focaccia, R. Foster, G.R. Horban, A. Lonjon-Domanec, I. DeMasi, R. Picchio, G. Witek, J. Zeuzem, S.